Report Detail

Pharma & Healthcare Global (United States, European Union and China) Oral Rotavirus Vaccine Market Research Report 2019-2025

  • RnM3526373
  • |
  • 14 June, 2019
  • |
  • Global
  • |
  • 117 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

In 2019, the market size of Oral Rotavirus Vaccine is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Oral Rotavirus Vaccine.

This report studies the global market size of Oral Rotavirus Vaccine, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Oral Rotavirus Vaccine sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
GSK
Sanofi-Pasteur
Merck
CSL Biotherapies
LG Life Sciences
Crucell
China National Biotec Group
Hualan Biological Engineering
Sinovac Biotech
Dalian Hissen Bio-pharm

Market Segment by Product Type
Rotarix
RotaTeq
Rotavac
Rotavin-M1
Lanzhou Lamb

Market Segment by Application
Hospital
Vaccination Station
Other

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Oral Rotavirus Vaccine status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Oral Rotavirus Vaccine manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Oral Rotavirus Vaccine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Oral Rotavirus Vaccine Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Rotarix
      • 1.3.3 RotaTeq
      • 1.3.4 Rotavac
      • 1.3.5 Rotavin-M1
      • 1.3.6 Lanzhou Lamb
    • 1.4 Market Segment by Application
      • 1.4.1 Global Oral Rotavirus Vaccine Market Share by Application (2019-2025)
      • 1.4.2 Hospital
      • 1.4.3 Vaccination Station
      • 1.4.4 Other
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Oral Rotavirus Vaccine Market Size
      • 2.1.1 Global Oral Rotavirus Vaccine Revenue 2014-2025
      • 2.1.2 Global Oral Rotavirus Vaccine Sales 2014-2025
    • 2.2 Oral Rotavirus Vaccine Growth Rate by Regions
      • 2.2.1 Global Oral Rotavirus Vaccine Sales by Regions 2014-2019
      • 2.2.2 Global Oral Rotavirus Vaccine Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Oral Rotavirus Vaccine Sales by Manufacturers
      • 3.1.1 Oral Rotavirus Vaccine Sales by Manufacturers 2014-2019
      • 3.1.2 Oral Rotavirus Vaccine Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Oral Rotavirus Vaccine Revenue by Manufacturers (2014-2019)
      • 3.2.2 Oral Rotavirus Vaccine Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Oral Rotavirus Vaccine Market Concentration Ratio (CR5 and HHI)
    • 3.3 Oral Rotavirus Vaccine Price by Manufacturers
    • 3.4 Key Manufacturers Oral Rotavirus Vaccine Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Oral Rotavirus Vaccine Market
    • 3.6 Key Manufacturers Oral Rotavirus Vaccine Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Rotarix Sales and Revenue (2014-2019)
      • 4.1.2 RotaTeq Sales and Revenue (2014-2019)
      • 4.1.3 Rotavac Sales and Revenue (2014-2019)
      • 4.1.4 Rotavin-M1 Sales and Revenue (2014-2019)
      • 4.1.5 Lanzhou Lamb Sales and Revenue (2014-2019)
    • 4.2 Global Oral Rotavirus Vaccine Sales Market Share by Type
    • 4.3 Global Oral Rotavirus Vaccine Revenue Market Share by Type
    • 4.4 Oral Rotavirus Vaccine Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Oral Rotavirus Vaccine Sales by Application

    6 United States

    • 6.1 United States Oral Rotavirus Vaccine Breakdown Data by Company
    • 6.2 United States Oral Rotavirus Vaccine Breakdown Data by Type
    • 6.3 United States Oral Rotavirus Vaccine Breakdown Data by Application

    7 European Union

    • 7.1 European Union Oral Rotavirus Vaccine Breakdown Data by Company
    • 7.2 European Union Oral Rotavirus Vaccine Breakdown Data by Type
    • 7.3 European Union Oral Rotavirus Vaccine Breakdown Data by Application

    8 China

    • 8.1 China Oral Rotavirus Vaccine Breakdown Data by Company
    • 8.2 China Oral Rotavirus Vaccine Breakdown Data by Type
    • 8.3 China Oral Rotavirus Vaccine Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Oral Rotavirus Vaccine Breakdown Data by Company
    • 9.2 Rest of World Oral Rotavirus Vaccine Breakdown Data by Type
    • 9.3 Rest of World Oral Rotavirus Vaccine Breakdown Data by Application
    • 9.4 Rest of World Oral Rotavirus Vaccine Breakdown Data by Countries
      • 9.4.1 Rest of World Oral Rotavirus Vaccine Sales by Countries
      • 9.4.2 Rest of World Oral Rotavirus Vaccine Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 GSK
      • 10.1.1 GSK Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Oral Rotavirus Vaccine
      • 10.1.4 Oral Rotavirus Vaccine Product Introduction
      • 10.1.5 GSK Recent Development
    • 10.2 Sanofi-Pasteur
      • 10.2.1 Sanofi-Pasteur Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Oral Rotavirus Vaccine
      • 10.2.4 Oral Rotavirus Vaccine Product Introduction
      • 10.2.5 Sanofi-Pasteur Recent Development
    • 10.3 Merck
      • 10.3.1 Merck Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Oral Rotavirus Vaccine
      • 10.3.4 Oral Rotavirus Vaccine Product Introduction
      • 10.3.5 Merck Recent Development
    • 10.4 CSL Biotherapies
      • 10.4.1 CSL Biotherapies Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Oral Rotavirus Vaccine
      • 10.4.4 Oral Rotavirus Vaccine Product Introduction
      • 10.4.5 CSL Biotherapies Recent Development
    • 10.5 LG Life Sciences
      • 10.5.1 LG Life Sciences Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Oral Rotavirus Vaccine
      • 10.5.4 Oral Rotavirus Vaccine Product Introduction
      • 10.5.5 LG Life Sciences Recent Development
    • 10.6 Crucell
      • 10.6.1 Crucell Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Oral Rotavirus Vaccine
      • 10.6.4 Oral Rotavirus Vaccine Product Introduction
      • 10.6.5 Crucell Recent Development
    • 10.7 China National Biotec Group
      • 10.7.1 China National Biotec Group Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Oral Rotavirus Vaccine
      • 10.7.4 Oral Rotavirus Vaccine Product Introduction
      • 10.7.5 China National Biotec Group Recent Development
    • 10.8 Hualan Biological Engineering
      • 10.8.1 Hualan Biological Engineering Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Oral Rotavirus Vaccine
      • 10.8.4 Oral Rotavirus Vaccine Product Introduction
      • 10.8.5 Hualan Biological Engineering Recent Development
    • 10.9 Sinovac Biotech
      • 10.9.1 Sinovac Biotech Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Oral Rotavirus Vaccine
      • 10.9.4 Oral Rotavirus Vaccine Product Introduction
      • 10.9.5 Sinovac Biotech Recent Development
    • 10.10 Dalian Hissen Bio-pharm
      • 10.10.1 Dalian Hissen Bio-pharm Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Oral Rotavirus Vaccine
      • 10.10.4 Oral Rotavirus Vaccine Product Introduction
      • 10.10.5 Dalian Hissen Bio-pharm Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Oral Rotavirus Vaccine Sales Channels
      • 11.2.2 Oral Rotavirus Vaccine Distributors
    • 11.3 Oral Rotavirus Vaccine Customers

    12 Market Forecast

    • 12.1 Global Oral Rotavirus Vaccine Sales and Revenue Forecast 2019-2025
    • 12.2 Global Oral Rotavirus Vaccine Sales Forecast by Type
    • 12.3 Global Oral Rotavirus Vaccine Sales Forecast by Application
    • 12.4 Oral Rotavirus Vaccine Forecast by Regions
      • 12.4.1 Global Oral Rotavirus Vaccine Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Oral Rotavirus Vaccine Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Summary:
      Get latest Market Research Reports on Oral Rotavirus Vaccine. Industry analysis & Market Report on Oral Rotavirus Vaccine is a syndicated market report, published as Global (United States, European Union and China) Oral Rotavirus Vaccine Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Oral Rotavirus Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,538.72
      3,808.08
      5,077.44
      3,017.60
      4,526.40
      6,035.20
      499,084.80
      748,627.20
      998,169.60
      275,880.80
      413,821.20
      551,761.60
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report